Related Experiment Video
Updated: Mar 7, 2026

09:56
Detection of Protease Activity by Fluorescent Peptide Zymography
Published on: January 20, 2019
13.7K
Nonpeptide-Based Small-Molecule Probe for Fluorogenic and Chromogenic Detection of Chymotrypsin.
Lei Wu1, Shu-Hou Yang1, Hao Xiong1
1Key Laboratory of Pesticide and Chemical Biology of Ministry of Education, College of Chemistry, Central China Normal University , Wuhan 430079, P.R. China.
Analytical Chemistry
|February 24, 2017
Summary
A novel nonpeptide probe detects chymotrypsin with high sensitivity and specificity. This small-molecule tool offers advantages over peptide substrates for drug discovery and disease diagnosis.
Area of Science:
- Biochemistry
- Chemical Biology
- Molecular Probes
Background:
- Chymotrypsin is a key enzyme in various physiological processes.
- Existing peptide-based substrates for chymotrypsin detection have limitations.
- Development of sensitive and specific detection methods is crucial for research and diagnostics.
Purpose of the Study:
- To develop and characterize a novel nonpeptide-based small-molecule probe for chymotrypsin detection.
- To evaluate the probe's specificity, sensitivity, and binding affinity compared to established substrates.
- To demonstrate the probe's utility in inhibitor characterization and potential applications in drug discovery and disease diagnosis.
Main Methods:
- Rational design of a nonpeptide probe mimicking peptide substrates.
- Optimization of the probe's recognition group.
- Fluorogenic and chromogenic assays to evaluate probe performance.
- Binding affinity and catalytic efficiency measurements.
- Application in inhibitor characterization studies.
Main Results:
- The refined probe 2 exhibits high specificity for chymotrypsin.
- Probe 2 demonstrates a 25-fold enhancement in fluorescence and absorbance upon catalysis.
- It shows a 5-fold higher binding affinity and comparable catalytic efficiency to AMC-FPAA-Suc.
- Successful application in characterizing chymotrypsin inhibitors.
Conclusions:
- Probe 2 is the first nonpeptide-based small-molecule probe for chymotrypsin.
- It offers advantages in structural simplicity and high sensitivity over peptide-based substrates.
- This probe serves as a valuable molecular tool for drug discovery and diagnosing chymotrypsin-related diseases.

